Cargando…

Preliminary assessment of neck circumference in benign prostatic hyperplasia in patients with metabolic syndrome

OBJECTIVES: To investigate the impact of neck circumference (NC) in the treatment of bening prostatic hyperplasia (BPH) patients with metabolic syndrome (MtS). Additionally, we determined dose response to alpha-blockers and cut-off values for NC and waist circumference (WC), in these patients. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akin, Yigit, Gulmez, Hakan, Ates, Erhan, Gulum, Mehmet, Savas, Murat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293389/ https://www.ncbi.nlm.nih.gov/pubmed/28124531 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0139

Ejemplares similares

Re: Preliminary assessment of neck circumference in benign prostatic hyperplasia in patients with metabolic syndrome
por: Besiroglu, Huseyin, et al.
Publicado: (2017)

Metabolic syndrome and benign prostatic hyperplasia: An update
por: Ngai, Ho-Yin, et al.
Publicado: (2017)

Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
por: Rył, Aleksandra, et al.
Publicado: (2015)

Benign Prostatic Hyperplasia
Publicado: (2015)

Chromosomal aberrations in benign prostatic hyperplasia patients
por: Altok, Muammer, et al.
Publicado: (2016)

Evaluation of apoptosis indexes in currently used oral alpha- blockers in prostate: a pilot study
por: Demir, Mehmet, et al.
Publicado: (2018)

Impact of Metabolic Syndrome on Response to Medical Treatment of Benign Prostatic Hyperplasia
por: Cyrus, Ali, et al.
Publicado: (2014)

Comparison of Alpha Blockers in Treatment of Premature Ejaculation: A Pilot Clinical Trial
por: Akin, Yigit, et al.
Publicado: (2013)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

A huge benign prostatic hyperplasia presenting with renal failure
por: Basatac, Cem, et al.
Publicado: (2015)

Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
por: Agamia, Naglaa F., et al.
Publicado: (2016)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Intraprostatic Injection of Alcohol Gel for the Treatment of Benign Prostatic Hyperplasia: Preliminary Clinical Results
por: Larson, Benjamin T., et al.
Publicado: (2006)

Transurethral Microwave Thermotherapy (TUMT) in the Treatment of Benign Prostatic Hyperplasia: A Preliminary Report
por: Ziętek, Roger J., et al.
Publicado: (2021)

Prostatic Artery Embolization as a Primary Treatment for Benign Prostatic Hyperplasia: Preliminary Results in Two Patients
por: Carnevale, Francisco Cesar, et al.
Publicado: (2009)

Does Metabolic Syndrome or its Components Correlate With Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients?
por: Telli, Onur, et al.
Publicado: (2015)

Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia
por: SANCER, Okan, et al.
Publicado: (2022)

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kadihasanoglu, Mustafa, et al.
Publicado: (2015)

The authors reply: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kabir, Ali, et al.
Publicado: (2015)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Fibronectin Pattern in Benign Hyperplasia and Cancer of the Prostate
por: Janković, Miroslava M., et al.
Publicado: (2008)

Genetic alterations in benign prostatic hyperplasia patients
por: Mohamed, Hanaa Mahmoud, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mbkki1eaf6lgleajehtt3usnug